Literature DB >> 6395140

Pharmacological manipulation of complement system.

S S Asghar.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6395140

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  11 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  Influence of mouse genotype on passive systemic anaphylaxis by immune complexes.

Authors:  A Portolés; J M Rojo; R Díaz
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

3.  Treatment of vasculitis with chlorpromazine and dapsone.

Authors:  S S Asghar; W Westerhof; P K Das; F C Jansen; R H Cormane
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytes.

Authors:  A M Verweij-van Vught; B J Appelmelk; A B Groeneveld; M Sparrius; L G Thijs; D M MacLaren
Journal:  Agents Actions       Date:  1987-12

5.  In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).

Authors:  M Etievant; B Leluc; B David
Journal:  Agents Actions       Date:  1988-06

6.  Suramin inhibits the mixed lymphocyte reaction by suppressing lymphokine production.

Authors:  M Shenoy; B MacPherson; P Christadoss
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

7.  Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B.

Authors:  C W Clardy
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.

Authors:  M Ling; S J Piddlesden; B P Morgan
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 9.  Recent developments in low molecular weight complement inhibitors.

Authors:  Hongchang Qu; Daniel Ricklin; John D Lambris
Journal:  Mol Immunol       Date:  2009-10-02       Impact factor: 4.407

10.  Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes.

Authors:  V R Muzykantov; M D Smirnov; G P Samokhin
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.